1-2 of 2
Michelle Matzko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TSC-100 and TSC-101 Demonstrate the Potential to Reduce Relapse Rates and Increase Relapse-Free Survival in Patients with AML, ALL, or MDS Undergoing Allogeneic HCT with Reduced Intensity Conditioning (RIC): Preliminary Results from the Phase 1 Alloha Trial

MHD Monzr M. Al Malki, Alla Keyzner, Uday Popat, Yi-Bin Chen, Hyung C Suh, Tania Jain, Melhem M. Solh, Anson Snow, Saar Gill, Lohith Gowda, Joseph Uberti, Erica Buonomo, Yun Wang, Nancy Nabilsi, Timothy White, Cuong Nguyen, Jim Murray, Gavin MacBeath, Chrystal Louis, Shrikanta Chattopadhyay, Michelle Matzko, Ran Reshef
Journal: Blood
Blood (2024) 144 (Supplement 1): 924.
https://doi.org/10.1182/blood-2024-201526
Published: 2024
Journal Articles

Final Clinical Outcomes from a Phase 2 Trial of Posoleucel, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Prevention of Clinically Significant Viral Infections Post-HCT

Sanjeet S Dadwal, Jo-Anne H. Young, Michael W. Schuster, Jean A. Yared, Gary Douglas Myers, Michelle Matzko, Sama Adnan, Joshua A. Hill, Rajat Bansal
Journal: Blood
Blood (2022) 140 (Supplement 1): 878–879.
https://doi.org/10.1182/blood-2022-169122
Published: 2022